Table 2.
Recorded symptoms and comorbidities characterizing the recruited individuals for each group.
| Emergency | Hospital Ward | ICU | Deceased | |||||
|---|---|---|---|---|---|---|---|---|
| M (76) | F (104) | M (105) | F (100) | M (14) | F (11) | M (23) | F (12) | |
| COVID-19 symptoms | ||||||||
| Fever | 30 (39.47%) | 58 (55.77%) | 55 (52.38%) | 43 (43.00%) | 5 (35.71%) | 5 (45.45%) | 11 (47.83%) | 7 (58.33%) |
| Cough | 26 (34.21%) | 48 (46.15%) | 36 (34.29%) | 28 (28.00%) | 1 (7.14%) | 2 (18.18%) | 8 (34.78%) | 3 (25.00%) |
| Dyspnea | 14 (18.42%) | 30 (28.85%) | 42 (40.00%) | 31 (31.00%) | 6 (42.86%) | 6 (54.55%) | 15 (65.22%) | 9 (75.00%) |
| Asthenia | 10 (13.16%) | 23 (22.12%) | 8 (7.62%) | 12 (12.00%) | 2 (14.29%) | 3 (27.27%) | 3 (13.04%) | 2 (16.67%) |
| Rhinitis | 6 (7.89%) | 5 (4.81%) | 6 (5.71%) | 2 (2.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (8.33%) |
| Memory deficits | 0 (0.00%) | 0 (0.00%) | 1 (0.95%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (4.35%) | 1 (8.33%) |
| Vertigo | 2 (2.63%) | 3 (2.88%) | 0 (0.00%) | 4 (4.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Anosmia | 1 (1.32%) | 2 (1.92%) | 1 (0.95%) | 4 (4.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (8.33%) |
| Ageusia | 1 (1.32%) | 2 (1.92%) | 1 (0.95%) | 2 (2.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (8.33%) |
| Depression or anxiety | 3 (3.95%) | 2 (1.92%) | 1 (0.95%) | 4 (4.00%) | 1 (7.14%) | 0 (0.00%) | 0 (0.00%) | 1 (8.33%) |
| Brain fog | 1 (1.32%) | 0 (0.00%) | 1 (0.95%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (4.35%) | 0 (0.00%) |
| Epistaxis | 0 (0.00%) | 0 (0.00%) | 1 (0.95%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (8.33%) |
| Arthralgia or myalgia | 12 (15.79%) | 32 (30.77%) | 7 (6.67%) | 7 (7.00%) | 2 (14.29%) | 1 (9.09%) | 0 (0.00%) | 2 (16.67%) |
| Headache | 8 (10.53%) | 14 (13.46%) | 6 (5.71%) | 9 (9.00%) | 0 (0.00%) | 1 (9.09%) | 0 (0.00%) | 0 (0.00%) |
| Paresthesia | 3 (3.95%) | 0 (0.00%) | 0 (0.00%) | 2 (2.00%) | 1 (7.14%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Sore throat | 11(14.47%) | 4 (3.85%) | 6 (5.71%) | 8 (8.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Comorbidities | ||||||||
| Lung diseases | 8 (10.53%) | 11 (10.58%) | 12 (11.43%) | 21 (21.00%) | 4 (28.57%) | 3 (27.27%) | 2 (8.70%) | 2 (16.67%) |
| Cardiac diseases | 15 (19.74%) | 22 (21.15%) | 54 (51.43%) | 54 (54.00%) | 9 (64.29%) | 6 (54.55%) | 16 (69.57%) | 10 (83.33%) |
| Dyslipidemia | 2 (2.63%) | 2 (1.92%) | 11 (10.48%) | 9 (9.00%) | 2 (14.29% | 0 (0.00%) | 1 (4.35%) | 1 (8.33%) |
| Chronic Renal Failure | 0 (0.00%) | 2 (1.92%) | 11 (10.48%) | 11 (11.00%) | 2 (14.29% | 1 (9.09%) | 6 (26.09%) | 2 (16.67%) |
| Oncological diseases | 3 (3.95%) | 12 (11.54%) | 13 (12.38% | 15 (15.00%) | 1 (7.14%) | 2 (18.18%) | 9 (39.13%) | 3 (2500%) |
| Diabetes | 2 (2.63%) | 2 (1.92%) | 19 (18.10%) | 18 (18.00%) | 3 (21.43%) | 2 (18.18%) | 3 (13.04%) | 2 (16.67%) |
| Gastrointestinal diseases | 9 (11.84%) | 8 (7.69%) | 11 (10.48%) | 10 (10.00%) | 4 (28.57%) | 2 (18.18%) | 4 (17.39%) | 3 (25.00%) |
| Neurological or psychiatric diseases | 5 (6.58%) | 12 (11.54%) | 15 (14.29%) | 22 (22.00%) | 3 (21.43% | 6 (54.55%) | 8 (34.78%) | 4 (33.33%) |
| Urologic diseases | 5 (6.58%) | 5 (4.81%) | 8 (7.62%) | 5 (5.00%) | 3 (21.43% | 1 (9.09%) | 6 (26.09%) | 0 (0.00%) |
| Ophthalmological diseases | 0 (0.00%) | 1 (0.96%) | 3 (2.86%) | 3 (3.00%) | 1 (7.14%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Immunological, rheumatological or hematological diseases | 7 (9.21%) | 19 (18.27%) | 16 (15.24%) | 14 (14.00%) | 1 (7.14%) | 0 (0.00%) | 4 (17.39%) | 2 (16.67%) |